Ivana Magovcevic-liebisch - Net Worth and Insider Trading
Ivana Magovcevic-liebisch Net Worth
The estimated net worth of Ivana Magovcevic-liebisch is at least $2 Million dollars as of 2024-05-23. Ivana Magovcevic-liebisch is the EVP; COO of Dyax Corp and owns about 40,625 shares of Dyax Corp (DYAX) stock worth over $2 Million. Ivana Magovcevic-liebisch is the President and CEO of Vigil Neuroscience Inc and owns about 207,687 shares of Vigil Neuroscience Inc (VIGL) stock worth over $742,481. Ivana Magovcevic-liebisch is also the Director of Applied Genetic Technologies Corp and owns about 3,000 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $1,181. Details can be seen in Ivana Magovcevic-liebisch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ivana Magovcevic-liebisch has not made any transactions after 2023-11-20 and currently still holds the listed stock(s).
Transaction Summary of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ivana Magovcevic-liebisch owns 5 companies in total, including Spyre Therapeutics Inc (SYRE) , Applied Genetic Technologies Corp (AGTC) , and Dyax Corp (DYAX) among others .
Click here to see the complete history of Ivana Magovcevic-liebisch’s form 4 insider trades.
Insider Ownership Summary of Ivana Magovcevic-liebisch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SYRE | Spyre Therapeutics Inc | 2018-03-22 | director |
AGTC | Applied Genetic Technologies Corp | 2016-11-16 | director |
DYAX | Dyax Corp | 2013-03-29 | EVP; Chief Operating Officer |
2021-07-21 | director | ||
2023-11-20 | director & President and CEO |
Ivana Magovcevic-liebisch Latest Holdings Summary
Ivana Magovcevic-liebisch currently owns a total of 3 stocks. Among these stocks, Ivana Magovcevic-liebisch owns 40,625 shares of Dyax Corp (DYAX) as of March 6, 2013, with a value of $2 Million and a weighting of 67.72%. Ivana Magovcevic-liebisch owns 207,687 shares of Vigil Neuroscience Inc (VIGL) as of November 20, 2023, with a value of $742,481 and a weighting of 32.22%. Ivana Magovcevic-liebisch also owns 3,000 shares of Applied Genetic Technologies Corp (AGTC) as of November 16, 2016, with a value of $1,181 and a weighting of 0.05%.
Latest Holdings of Ivana Magovcevic-liebisch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DYAX | Dyax Corp | 2013-03-06 | 40,625 | 38.41 | 1,560,406 |
VIGL | Vigil Neuroscience Inc | 2023-11-20 | 207,687 | 3.58 | 742,481 |
AGTC | Applied Genetic Technologies Corp | 2016-11-16 | 3,000 | 0.39 | 1,181 |
Holding Weightings of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Form 4 Trading Tracker
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 215,359 shares on March 6, 2013, which brought Ivana Magovcevic-liebisch around $861,436.
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 2 transactions in Vigil Neuroscience Inc (VIGL) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vigil Neuroscience Inc is the acquisition of 4,000 shares on November 20, 2023, which cost Ivana Magovcevic-liebisch around $15,000.
According to the SEC Form 4 filings, Ivana Magovcevic-liebisch has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the acquisition of 3,000 shares on November 16, 2016, which cost Ivana Magovcevic-liebisch around $28,890.
Insider Trading History of Ivana Magovcevic-liebisch
- 1
Ivana Magovcevic-liebisch Trading Performance
GuruFocus tracks the stock performance after each of Ivana Magovcevic-liebisch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ivana Magovcevic-liebisch is 25.08%. GuruFocus also compares Ivana Magovcevic-liebisch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ivana Magovcevic-liebisch within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ivana Magovcevic-liebisch's insider trading performs compared to the benchmark.
Performance of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Ownership Network
Ownership Network List of Ivana Magovcevic-liebisch
Ownership Network Relation of Ivana Magovcevic-liebisch
Ivana Magovcevic-liebisch Owned Company Details
What does Spyre Therapeutics Inc do?
Who are the key executives at Spyre Therapeutics Inc?
Ivana Magovcevic-liebisch is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .
Spyre Therapeutics Inc (SYRE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spyre Therapeutics Inc Insider Transactions
Ivana Magovcevic-liebisch Mailing Address
Above is the net worth, insider trading, and ownership report for Ivana Magovcevic-liebisch. You might contact Ivana Magovcevic-liebisch via mailing address: 300 Technology Square, 8th Floor, Cambridge Ma 02139.